Galbot Valued at US$3 Billion in Record-Breaking Funding for Chinese Robotics
Galbot, a Chinese embodied artificial intelligence startup, has secured over US$300 million in its latest financing round, propelling its valuation to US$3 billion. The deal marks the largest single funding round and highest valuation in China’s burgeoning humanoid robotics sector to date, highlighting the heavy capital flowing into hardware innovation as 2025 draws to a close.
The fresh capital was led by the China Mobile Chain Chief Fund, a prominent state-linked investment vehicle. The round also attracted a coalition of industrial giants and financial institutions, including CICC Capital, CAS Investment Management, PEPM, HTCC Fund, and Miracle Automation Engineering. Notably, the Beijing-based company also secured backing from international investors in Singapore and the Middle East for the first time.
This transaction brings Galbot’s cumulative funding to approximately US$800 million since its inception in May 2023. The US$3 billion valuation places it ahead of domestic rivals such as Unitree and Agibot, signaling a consolidation of resources toward top-tier players. The influx of strategic capital from state enterprises and international funds suggests a shift in the sector from early-stage technological verification to industrial-scale application.
With the new funding, Galbot aims to accelerate the commercial deployment of its robots in industrial and service scenarios. The company has reportedly secured orders for thousands of units and established partnerships with major automotive and battery manufacturers, including Contemporary Amperex Technology and Toyota Motor, positioning itself to capitalize on the anticipated commercial watershed for embodied AI in 2026.
Capital Surge and Strategic Backing
The over US$300 million injection underscores the aggressive pace of capital accumulation in China’s hard tech sector. According to sources familiar with the matter, the high entry threshold and rapid financing pace meant many potential investors were unable to participate. This round follows a series of substantial capital raises over the past two years.
In June 2024, Galbot completed an angel round totaling RMB 700 million yuan (US$96 million), backed by strategic investors including Meituan and BAIC Capital. Subsequent rounds in November 2024 and June 2025 brought in another RMB 500 million yuan (US$69 million) and RMB 1.1 billion yuan (US$151 million) respectively, with the latter introducing battery giant CATL as a strategic investor. Galbot remains the only embodied AI large model enterprise invested in by CATL.
The composition of the latest shareholder list reflects a "state capital plus industrial capital" structure. The involvement of the China Mobile Chain Chief Fund and other domestic chain-owner enterprises indicates a focus on empowering the full-scenario industrialization of humanoid robots. Meanwhile, the addition of Middle Eastern and Singaporean capital opens avenues for global market expansion.
Industrial and Commercial Deployment
Galbot has begun transitioning from prototype demonstration to mass production and deployment. The company focuses on two primary scenarios: industrial manufacturing and unmanned commercial services.
In the industrial sector, Galbot has achieved autonomous operation within factory environments continuously. It has deepened cooperation with industry leaders such as Bosch Group, Hyundai Motor, SAIC, Zeekr and Great Wall. The company reports a cumulative order volume reaching thousands of units, with robots performing tasks like carrying and handling on production lines.
In the commercial service domain, the company has deployed its "Galaxy Capsule" solution—a fully autonomous service robot system—in major landmarks and commercial districts including the Beijing Summer Palace and Chengdu Chunxi Road. Furthermore, in late 2024, Galbot partnered with Eyebright Medical to launch a 24-hour smart medical store, utilizing humanoid robots for autonomous operations, a model now being replicated in cities like Shanghai, Guangzhou, and Shenzhen.
Technology Strategy: Brain-First Approach
Founded by Wang He, a professor at Peking University and former PhD researcher at Stanford University, Galbot differentiates itself with a "brain-first, body-pragmatic" technological strategy. Unlike competitors focusing heavily on bipedal locomotion, Galbot utilizes a wheeled chassis combined with folding legs. This design provides stability and cost advantages in flat environments like pharmacies and factories, allowing engineering resources to focus on grasp generalization and logical reasoning.
The company relies on a "Sim2Real" approach, utilizing large-scale synthetic data to overcome data scarcity in embodied AI. In 2025, Galbot released several key models, including NavFoM, a global cross-body navigation foundation model capable of long-range autonomous navigation without mapping, and DexNDM, a dexterous hand neural dynamic model that enables precise manipulation capabilities like screw tightening without traditional trajectory programming.
Market Consolidation and Future Outlook
The Chinese embodied intelligence sector has experienced a financing boom in 2025, with over 150 startups operating in the space. However, industry insiders bear similarities to the electric vehicle industry's trajectory between 2016 and 2020, where a crowded field eventually consolidated into a few technically robust players.
While the sector is still in its early stages relative to global developments, the involvement of large-scale industrial capital suggests a belief that 2026 will be a pivotal year for commercialization. Investors note that while significant foam exists due to high innovation activity, the funding landscape is quickly narrowing around leading "unicorns" capable of delivering tangible productivity improvements rather than just technological demonstrations.